97 related articles for article (PubMed ID: 30942197)
21. PTX3 activates POSTN and promotes the progression of glioblastoma via the MAPK/ERK signalling axis.
Wang Y; Wang B; Cao W; Xu X
Biochem Biophys Res Commun; 2024 Apr; 703():149665. PubMed ID: 38359612
[TBL] [Abstract][Full Text] [Related]
22. Interferon-α coincides with suppressed levels of pentraxin-3 (PTX3) in systemic lupus erythematosus and regulates leucocyte PTX3 in vitro.
Wirestam L; Enocsson H; Skogh T; Eloranta ML; Rönnblom L; Sjöwall C; Wetterö J
Clin Exp Immunol; 2017 Jul; 189(1):83-91. PubMed ID: 28257596
[TBL] [Abstract][Full Text] [Related]
23. Pentraxin 3, long expression in mononuclear cells of patients with acute coronary syndrome: Correlation with C-reactive protein and matrix metalloproteinase-9 levels.
Ma R; Zhang W; Wang T; He X; Huang Z; Zhu J; Yao Z
J Int Med Res; 2014 Jun; 42(3):677-83. PubMed ID: 24709882
[TBL] [Abstract][Full Text] [Related]
24. Elevated plasma level of pentraxin-3 predicts in-hospital and 30-day clinical outcomes in patients with non-ST-segment elevation myocardial infarction who have undergone percutaneous coronary intervention.
Guo R; Li Y; Wen J; Li W; Xu Y
Cardiology; 2014; 129(3):178-88. PubMed ID: 25323314
[TBL] [Abstract][Full Text] [Related]
25. Pentraxin-3 as a local inflammatory marker in chronic spontaneous urticaria.
Kasperska-Zajac A; Grzanka A; Misiolek M; Mazur B; Machura E
Cytokine; 2015 Dec; 76(2):566-568. PubMed ID: 25982553
[TBL] [Abstract][Full Text] [Related]
26. Astrocyte-Derived Pentraxin 3 Supports Blood-Brain Barrier Integrity Under Acute Phase of Stroke.
Shindo A; Maki T; Mandeville ET; Liang AC; Egawa N; Itoh K; Itoh N; Borlongan M; Holder JC; Chuang TT; McNeish JD; Tomimoto H; Lok J; Lo EH; Arai K
Stroke; 2016 Apr; 47(4):1094-100. PubMed ID: 26965847
[TBL] [Abstract][Full Text] [Related]
27. Pentraxin 3: a novel biomarker for predicting progression from prostatic inflammation to prostate cancer.
Stallone G; Cormio L; Netti GS; Infante B; Selvaggio O; Fino GD; Ranieri E; Bruno F; Prattichizzo C; Sanguedolce F; Tortorella S; Bufo P; Grandaliano G; Carrieri G
Cancer Res; 2014 Aug; 74(16):4230-8. PubMed ID: 24950910
[TBL] [Abstract][Full Text] [Related]
28. Serum pentraxin 3 is a novel marker in Crohn's disease.
Chen J; Xu X; Xia L; Xi X; Liu B; Yang M
Mol Med Rep; 2015 Jul; 12(1):543-6. PubMed ID: 25760650
[TBL] [Abstract][Full Text] [Related]
29. [Expression of pentraxin-3 in placentas and its relationship with severe preeclampsia].
Zhou P; Luo X; Qi HB
Zhonghua Fu Chan Ke Za Zhi; 2012 May; 47(5):347-50. PubMed ID: 22883522
[TBL] [Abstract][Full Text] [Related]
30. Systemic and Ocular Long Pentraxin 3 in Patients with Age-Related Macular Degeneration.
Juel HB; Faber C; Munthe-Fog L; Bastrup-Birk S; Reese-Petersen AL; Falk MK; Singh A; Sørensen TL; Garred P; Nissen MH
PLoS One; 2015; 10(7):e0132800. PubMed ID: 26176960
[TBL] [Abstract][Full Text] [Related]
31. Elevated Pentraxin 3 in bone metastatic breast cancer is correlated with osteolytic function.
Choi B; Lee EJ; Song DH; Yoon SC; Chung YH; Jang Y; Kim SM; Song Y; Kang SW; Yoon SY; Chang EJ
Oncotarget; 2014 Jan; 5(2):481-92. PubMed ID: 24457902
[TBL] [Abstract][Full Text] [Related]
32. Decreased Expression of miR-15b in Human Gliomas is Associated with Poor Prognosis.
Sun G; Yan S; Shi L; Wan Z; Jiang N; Li M; Guo J
Cancer Biother Radiopharm; 2015 May; 30(4):169-73. PubMed ID: 25811315
[TBL] [Abstract][Full Text] [Related]
33. Pentraxin 3 and C-reactive protein in severe meningococcal disease.
Sprong T; Peri G; Neeleman C; Mantovani A; Signorini S; van der Meer JW; van Deuren M
Shock; 2009 Jan; 31(1):28-32. PubMed ID: 18650775
[TBL] [Abstract][Full Text] [Related]
34. Relationship Between Plasma Pentraxin 3 Concentration and Platelet Indices in Patients With Stable Coronary Artery Disease.
Korzonek-Szlacheta I; Danikiewicz A; Szkodziński J; Nowak J; Lekston A; Gąsior M; Zubelewicz-Szkodzińska B; Hudzik B
Angiology; 2018 Mar; 69(3):264-269. PubMed ID: 28946774
[TBL] [Abstract][Full Text] [Related]
35. Pentraxin 3 as a biomarker of local inflammatory response to vascular injury in systemic lupus erythematosus.
Cieślik P; Hrycek A
Autoimmunity; 2015 Jun; 48(4):242-50. PubMed ID: 25401491
[TBL] [Abstract][Full Text] [Related]
36. PTX3: A Potential Biomarker in Thyroid Associated Ophthalmopathy.
Mou P; Chen Z; Jiang L; Cheng J; Wei R
Biomed Res Int; 2018; 2018():5961974. PubMed ID: 29675428
[TBL] [Abstract][Full Text] [Related]
37. Knockdown of Pentraxin 3 suppresses tumorigenicity and metastasis of human cervical cancer cells.
Ying TH; Lee CH; Chiou HL; Yang SF; Lin CL; Hung CH; Tsai JP; Hsieh YH
Sci Rep; 2016 Jul; 6():29385. PubMed ID: 27377307
[TBL] [Abstract][Full Text] [Related]
38. Increase in tissue and circulating pentraxin3 levels in patients with aortic valve stenosis.
Naito Y; Tsujino T; Akahori H; Ohyanagi M; Mitsuno M; Miyamoto Y; Hao H; Hirota S; Masuyama T
Am Heart J; 2010 Oct; 160(4):685-91. PubMed ID: 20934563
[TBL] [Abstract][Full Text] [Related]
39. Clinical and prognostic implications of circulating pentraxin 3 levels in non ST-elevation acute coronary syndrome.
Eggers KM; Armstrong PW; Califf RM; Johnston N; Simoons ML; Venge P; James SK
Clin Biochem; 2013 Nov; 46(16-17):1655-9. PubMed ID: 24012697
[TBL] [Abstract][Full Text] [Related]
40. Knockdown of the inflammatory factor pentraxin-3 suppresses growth and invasion of lung adenocarcinoma through the AKT and NF-kappa B pathways.
Hu FQ; Qiao T; Xie X; Hu R; Xiao HB
J Biol Regul Homeost Agents; 2014; 28(4):649-57. PubMed ID: 25620175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
